Medscape

Switching from clopidogrel to prasugrel further reduces platelet function

Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
TCTMD

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

CHICAGO, IL—Prasugrel effectively decreases platelet reactivity compared with high dose clopidogrel in stable patients who respond poorly to the older antiplatelet agent after percutaneous coronary ...
TCTMD

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI ...

Indianapolis and Tokyo -- A new post-hoc sub-analysis of an important set of patients from the TRITON-TIMI 38 study – those identified as the "core clinical cohort" population – showed that treatment ...
Medscape

Prasugrel preferable to high-dose clopidogrel in diabetics?

Jacksonville, FL - Further evidence supporting the concept that prasugrel may be a more appropriate antiplatelet agent than even high-dose clopidogrel for diabetic patients has come from a new ...
Forbes

Ticagrelor Joins Clopidogrel And Prasugrel In Updated NSTEMI Guidelines

Ticagrelor (Brilinta, AstraZeneca) gains equal standing with prasugrel (Effient, Lilly) and clopdiogrel in the newly released focused update of the ACCF/AHA guidelines for unstable angina and ...
Forbes

TRILOGY At ESC: No Advantage For Prasugrel Over Clopidogrel In Medical ACS Patients

The newer antiplatelet agent prasugrel was no better than the old standby clopidogrel for treating patients with acute coronary syndrome (ACS) who are not undergoing revascularization. The results of ...
Science Daily

Prasugrel: Indications of an additional benefit for some patients, but also of greater harm, study finds

In order to better prevent blood clots, the drugs clopidogrel or prasugrel can be prescribed to patients with acute ischaemia of the heart muscle, in addition to acetylsalicylic acid (ASA).
FiercePharma

Mortality Data Presented for Patients Treated with Efient®/Effient® (Prasugrel) Who Underwent Isolated Coronary Artery Bypass Su

(3) Prasugrel-treated patients experienced a statistically significantly higher volume of chest tube blood loss at 12 hours post-CABG compared to the clopidogrel-treated patients (655 +/- 580 ...
MM&M

High hopes for prasugrel hit by safety worries

Clinical trials of a much-anticipated compound from Eli Lilly brought mixed results, causing analysts to further cool on the drug. The Phase III trial, a head-to-head study of prasugrel vs. the ...
Healio

ExcelsiorLOAD: Prasugrel superior to clopidogrel for platelet inhibition in stable patients undergoing PCI

Please provide your email address to receive an email when new articles are posted on . Prasugrel 60 mg was associated with faster and more effective platelet inhibition compared with clopidogrel in ...
FiercePharma

Effient® (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Coho

INDIANAPOLIS and TOKYO, Aug. 15, 2011 /PRNewswire/ -- A new post-hoc sub-analysis of an important set of patients from the TRITON-TIMI 38 study – those identified as the "core clinical cohort" ...